---
$id: https://graph.org.ai/products/commodity/51171813
$type: Product
source: UNSPSC
code: "51171813"
title: "Metopimazine"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metopimazine

**UNSPSC Code**: 51171813
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiemetic agent with the molecular formula C22H27N3O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 238S75V9AV, chemically known as 4-piperidinecarboxamide, 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)- but generally known as metopimazine, which bears US NIH Compound Identifier 26388. European Medicines Agency schedules Metopimazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08908MIG. The term METOPIMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules metopimazine in its Anatomical Therapeutic Chemical (ATC) Classification. METOPIMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metopimazine under HS 29343090 and SITC 51578. As of Q4 2014, METOPIMAZINE remains the US FDA Preferred Term for this commodity. Metopimazine bears US NLM identifiers UMLS ID C0066469 and NCI Concept Code C81497. SMILES: S1C2C(N(CCCN3CCC(CC3)C(=O)N)C3C1CCCC3)CC(S(=O)(=O)C)CC2.

